DJ
Therapeutic Areas
Navrogen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NAV-001 | Solid Tumors (MSLN+), e.g., Lung Adenocarcinoma, Mesothelioma | Preclinical |
| NAV-006 | Hematological Malignancies (CD20+), e.g., Non-Hodgkin’s Lymphoma | Preclinical |
| NAV-201 | Solid & Liquid Cancers | Preclinical |
| NAV-002 | Solid Tumors (FOLR1+) | Preclinical |
| NAV-003 | Solid Tumors (MSLN+) | Preclinical |
| NAV-004 | Solid Tumors | Preclinical |
| NAV-005 | Solid & Liquid Cancers | Preclinical |
| NAV-205 | Solid & Liquid Cancers | Preclinical |